EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers

Marita Helen Augustinussen, Garth D Tylden iD, Christine Hanssen Rinaldo iD

Viruses · 2023

DOI: 10.3390/v15030619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Marita Helen Augustinussen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway. Hauptthemen laut MEDLINE: BNT162 Vaccine, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Microbiology and Infection Control University Hospital of North Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To facilitate interpretation of clinical SARS-CoV-2 anti-spike IgG analyses post-vaccination, 82 healthcare workers were followed through three vaccination-regimens: two regimens were comprised of two doses of BNT162b2 three or six weeks apart, followed by a dose of mRNA-vaccine, and in the other regimen, the first dose was replaced by ChAdOx1 nCov-19. After each dose, anti-spike IgG was compared between regimens. As many participants became infected, anti-spike IgG persistence was compared between infected and uninfected participants. Thirteen to twenty-one days after the first dose, seroconversion, and the median anti-spike IgG level in the ChAdOx1 group was significantly lower than in the BNT162b2 groups (23 versus 68 and 73 AU/mL). The second dose caused a significant increase in anti-spike IgG, but the median level was lower in the BNT162b2-short-interval group (280 AU/mL), compared to the BNT162b2-long-interval (1075 AU/mL) and ChAdOx1 (1160 AU/mL) group. After the third dose, all groups showed increases to similar anti-spike IgG levels (2075–2390 AU/mL). Over the next half year, anti-spike IgG levels declined significantly in all groups, but appeared to persist longer after post-vaccination infection. This is the first three-dose study with one dose of ChAdOx1. Despite initial differences, all vaccine regimens gave similarly high antibody levels and persistence after the third dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BNT162 VaccineCOVID-19HumansCOVID-19 VaccinesChAdOx1 nCoV-19Longitudinal StudiesSARS-CoV-2VaccinationAntibodies, ViralHealth PersonnelImmunoglobulin G

Stichwörter der Autor:innen

BNT162b2ChAdOx1 nCoV-19Liaison S1/S2-IgGSARS-CoV-2 serologyantibody declinespike

Substanzen

BNT162 VaccineCOVID-19 VaccinesChAdOx1 nCoV-19Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway.
  • Department of Medical Biology, UiT The Arctic University of Norway, N-9037 Tromsø, Norway.
  • Metabolic and Renal Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, N-9037 Tromsø, Norway.

ORCID-Profile: Garth D Tylden, Christine Hanssen Rinaldo

Förderung

  • Department of Microbiology and Infection Control University Hospital of North Norway

Zitieren

APA

Augustinussen, M. H., Tylden, G. D., & Rinaldo, C. H. (2023). Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers. Viruses. https://doi.org/10.3390/v15030619

Vancouver

Augustinussen MH, Tylden GD, Rinaldo CH. Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers. Viruses. 2023. doi:10.3390/v15030619

BibTeX
@article{Augustinussen2023,
  author = {Augustinussen, Marita Helen and Tylden, Garth D and Rinaldo, Christine Hanssen},
  title = {Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15030619}
}
Kostenlos starten →